Federal Register / Vol. 89, No. 231 / Monday, December 2, 2024 / Notices 95215 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

CE25–027, Evaluate STEADI-based Fall 

Prevention in Assisted Living Facilities. 

Dates: March 4–5, 2025. 

Times: 10 a.m.–5 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Officer, National Center for 

Injury Prevention and Control, Centers 

for Disease Control and Prevention, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341. 

Telephone: (404) 639–6473; Email: 

AWilkes@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–28181 Filed 11–29–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C. 1009(d), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention, pursuant to Public Law 92– 

463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel; 

(SEP)—TS25–036, Identify and Evaluate 

Potential Risk Factors for ALS. 

Dates: February 25–26, 2025. 

Times: 10 a.m.–5 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Carlisha Gentles, Pharm.D., B.C.P.S., 

C.D.C.E.S., Scientific Review Officer, 

National Center for Injury Prevention 

and Control, Centers for Disease Control 

and Prevention, 4770 Buford Highway 

NE, Mailstop S106–9, Atlanta, Georgia 

30341. Telephone: (770) 488–1504; 

Email: CGentles@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–28182 Filed 11–29–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–6094–N] 

RIN 0938–ZB85 

Medicare, Medicaid, and Children’s 

Health Insurance Programs; Provider 

Enrollment Application Fee Amount for 

Calendar Year 2025 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces a 

$730.00 calendar year (CY) 2025 

application fee for institutional 

providers that are initially enrolling in 

the Medicare or Medicaid program or 

the Children’s Health Insurance 

Program (CHIP); revalidating their 

Medicare, Medicaid, or CHIP 

enrollment; or adding a new Medicare 

practice location. This fee is required 

with any enrollment application 

submitted on or after January 1, 2025, 

and on or before December 31, 2025. 

DATES: The application fee announced 

in this notice is effective on January 1, 

2025. 

FOR FURTHER INFORMATION CONTACT: 

Frank Whelan, (410) 786–1302. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the February 2, 2011 Federal 

Register (76 FR 5862), we published a 

final rule with comment period titled 

‘‘Medicare, Medicaid, and Children’s 

Health Insurance Programs; Additional 

Screening Requirements, Application 

Fees, Temporary Enrollment Moratoria, 

Payment Suspensions and Compliance 

Plans for Providers and Suppliers.’’ This 

rule finalized, among other things, 

provisions related to the submission of 

application fees as part of the Medicare, 

Medicaid, and CHIP provider 

enrollment processes. 

As provided in section 1866(j)(2)(C)(i) 

of the Social Security Act (the Act) and 

in 42 CFR 424.514, ‘‘institutional 

providers’’ that are initially enrolling in 

the Medicare or Medicaid programs or 

CHIP, revalidating their enrollment, or 

adding a new Medicare practice location 

are required to submit a fee with their 

enrollment application. An 

‘‘institutional provider’’ for purposes of 

Medicare is defined at § 424.502 as ‘‘any 

provider or supplier that submits a 

paper Medicare enrollment application 

using the CMS–855A, CMS–855B (not 

including physician and non-physician 

practitioner organizations), CMS–855S, 

or associated internet-based PECOS 

enrollment application.’’ As we 

explained in the February 2, 2011 final 

rule (76 FR 5914), in addition to the 

providers and suppliers subject to the 

application fee under Medicare, 

Medicaid-only and CHIP-only 

institutional providers would include 

nursing facilities, intermediate care 

facilities for persons with intellectual 

disabilities (ICF/IID), and psychiatric 

residential treatment facilities; they may 

also include other institutional provider 

types designated by a State in 

accordance with their approved State 

plan. 

As indicated in § 424.514 and 

§ 455.460, the application fee is not 

required for either of the following: 

• A Medicare physician or nonphysician practitioner submitting a 

CMS–855I. 

• A prospective or revalidating 

Medicaid or CHIP provider— 

++ Who is an individual physician or 

non-physician practitioner; or 

++ That is enrolled as an institutional 

provider in Title XVIII of the Act or 


ddrumheller on DSK120RN23PROD with NOTICES1
95216 Federal Register / Vol. 89, No. 231 / Monday, December 2, 2024 / Notices 

another State’s title XIX or XXI plan and 

has paid the application fee to a 

Medicare contractor or another State. 

II. Provisions of the Notice 

Section 1866(j)(2)(C)(i)(I) of the Act 

established a $500 application fee for 

institutional providers in CY 2010. 

Consistent with section 

1866(j)(2)(C)(i)(II) of the Act, 

§ 424.514(d)(2) states that for CY 2011 

and subsequent years, the preceding 

year’s fee will be adjusted by the 

percentage change in the consumer 

price index (CPI) for all urban 

consumers (all items; United States city 

average, CPI–U) for the 12-month period 

ending on June 30 of the previous year. 

Consequently, each year since 2011 we 

have published in the Federal Register 

an announcement of the application fee 

amount for the forthcoming CY based on 

this formula. Most recently, in the 

November 7, 2023 Federal Register (88 

FR 76754), we published a notice 

announcing a fee amount for the period 

of January 1, 2024 through December 31, 

2024 of $709.00. The $709.00 fee 

amount for CY 2024 was used to 

calculate the fee amount for 2025 as 

specified in § 424.514(d)(2). 

According to Bureau of Labor 

Statistics (BLS) data, the CPI–U increase 

for the period of July 1, 2023 through 

June 30, 2024 was 3.0 percent. (See 

https://www.bls.gov/news.release/ 

archives/cpi_07112024.htm.) As 

required by § 424.514(d)(2), the 

preceding year’s fee of $709 will be 

adjusted by 3.0 percent. This results in 

a CY 2025 application fee amount of 

$730.27 ($709 × 1.03). As we must 

round this to the nearest whole dollar 

amount, the resultant application fee 

amount for CY 2025 is $730. 

III. Collection of Information 

Requirements 

This document does not impose 

information collection requirements 

(that is, reporting, recordkeeping, or 

third-party disclosure requirements). 

Accordingly, there is no need for review 

by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995. 

However, it does reference previously 

approved information collections. The 

CMS–855A, CMS–855B, CMS–855I, and 

CMS–855S applications are approved 

under, respectively, OMB control 

numbers 0938–0685, 0938–1377, 0938– 

1355, and 0938–1056. 

IV. Regulatory Impact Statement 

A. Overall Impact 

We have examined the impacts of this 

notice as required by Executive Order 

12866 on Regulatory Planning and 

Review (September 30, 1993), Executive 

Order 13563 on Improving Regulation 

and Regulatory Review (January 18, 

2011), Executive Order 14094 titled 

‘‘Modernizing Regulatory Review’’ 

(April 6, 2023), the Regulatory 

Flexibility Act (RFA) (September 19, 

1980, Pub. L. 96–354), section 1102(b) of 

the Social Security Act, section 202 of 

the Unfunded Mandates Reform Act of 

1995 (March 22, 1995; Pub. L. 104–4), 

Executive Order 13132 on Federalism 

(August 4, 1999), and the Congressional 

Review Act (5 U.S.C. 804(2)). 

Executive Orders 12866 and 13563 

direct agencies to assess all costs and 

benefits of available regulatory 

alternatives and, if regulation is 

necessary, to select regulatory 

approaches that maximize net benefits 

(including potential economic, 

environmental, public health and safety 

effects, distributive impacts, and 

equity). The Executive Order 14094 

titled ‘‘Modernizing Regulatory Review’’ 

amends section 3(f)(1) of Executive 

Order 12866 (Regulatory Planning and 

Review). The amended section 3(f) of 

Executive Order 12866 defines a 

‘‘significant regulatory action’’ as an 

action that is likely to result in a rule 

(notice) that may: (1) have an annual 

effect on the economy of $200 million 

or more in any 1 year, (adjusted every 

3 years by the Administrator of OMB’s 

Office of Information and Regulatory 

Affairs (OIRA) for changes in gross 

domestic product); or adversely affect in 

a material way the economy, a sector of 

the economy, productivity, competition, 

jobs, the environment, public health or 

safety, or State, local, territorial, or tribal 

governments or communities; (2) create 

a serious inconsistency or otherwise 

interfere with an action taken or 

planned by another agency; (3) 

materially alter the budgetary impacts of 

entitlement grants, user fees, or loan 

programs or the rights and obligations of 

recipients thereof; or (4) raise legal or 

policy issues for which centralized 

review would meaningfully further the 

President’s priorities or the principles 

set forth in this Executive order, as 

specifically authorized in a timely 

manner by OIRA in each case. 

A regulatory impact analysis (RIA) 

must be prepared for notices with 

significant regulatory action/s and/or 

with significant effects as per section 

3(f)(1) of Executive Order 12866 ($200 

million or more in any 1 year). Based on 

our estimates, OIRA has determined that 

this rulemaking is not significant per 

section 3(f)(1) as measured by the $200 

million or more in any 1 year. 

As explained in this section of the 

notice, we estimate that the total cost of 

the increase in the application fee will 

not exceed $200 million. Therefore, this 

notice does not reach the $200 million 

economic threshold and is not 

considered a significant notice. 

B. Cost 

The costs associated with this notice 

involve the increase in the application 

fee amount that certain providers and 

suppliers must pay in CY 2025. The CY 

2025 cost estimates are as follows: 

1. Medicare 

Based on CMS data, we estimate that 

in CY 2025 approximately— 

• 13,151 newly enrolling institutional 

providers will be subject to and pay an 

application fee; and 

• 37,224 revalidating institutional 

providers will be subject to and pay an 

application fee. 

Using a figure of 50,375 (13,151 newly 

enrolling + 37,224 revalidating) 

institutional providers, we estimate an 

increase in the cost of the Medicare 

application fee requirement in CY 2025 

of $1,057,875 (or 50,375 × $21 (or $730 

minus $709)) from our CY 2024 

projections. 

2. Medicaid and CHIP 

Based on CMS and State statistics, we 

estimate that approximately 30,000 

(9,000 newly enrolling + 21,000 

revalidating) Medicaid and CHIP 

institutional providers will be subject to 

an application fee in CY 2025. Using 

this figure, we project an increase in the 

cost of the Medicaid and CHIP 

application fee requirement in CY 2025 

of $630,000 (or 30,000 × $21 (or $730 

minus $709)) from our CY 2024 

projections. 

3. Total 

Based on the foregoing, we estimate 

the total increase in the cost of the 

application fee requirement for 

Medicare, Medicaid, and CHIP 

providers and suppliers in CY 2025 to 

be $1,687,875 ($1,057,875 + $630,000) 

from our CY 2024 projections. 

We do not anticipate any negative 

impact on equity from the increase in 

the application fee amount, which we 

calculated in accordance with the 

requirements specified in statute and 

regulation. Prior application fee 

increases have had no such discernable 

effect, and we reiterate that the fee 

requirement does not apply to 

individual physicians and nonphysician practitioners completing the 

CMS–855I, who represent the 

overwhelming preponderance of the 

more than 2 million Medicare-enrolled 

providers and suppliers. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 231 / Monday, December 2, 2024 / Notices 95217 

The RFA requires agencies to analyze 

options for regulatory relief of small 

businesses. For purposes of the RFA, 

small entities include small businesses, 

nonprofit organizations, and small 

governmental jurisdictions. Most 

hospitals and most other providers and 

suppliers are small entities, either by 

nonprofit status or by having revenues 

of less than $9 million to $47 million in 

any 1 year. Individuals and States are 

not included in the definition of a small 

entity. As we stated in the RIA for the 

February 2, 2011 final rule (76 FR 5952), 

we do not believe that the application 

fee will have a significant impact on 

small entities. 

In addition, section 1102(b) of the Act 

requires us to prepare an RIA if a rule 

(notice) may have a significant impact 

on the operations of a substantial 

number of small rural hospitals. This 

analysis must conform to the provisions 

of section 604 of the RFA. For purposes 

of section 1102(b) of the Act, we define 

a small rural hospital as a hospital that 

is located outside of a metropolitan 

statistical area and has fewer than 100 

beds. We are not preparing an analysis 

for section 1102(b) of the Act, because 

the Secretary has certified that this 

notice will not have a significant impact 

on the operations of a substantial 

number of small rural hospitals. 

Section 202 of the Unfunded 

Mandates Reform Act of 1995 also 

requires that agencies assess anticipated 

costs and benefits before issuing any 

rule whose mandates require spending 

in any 1 year of $100 million in 1995 

dollars, updated annually for inflation. 

In 2024, that threshold is approximately 

$183 million. This notice would not 

impose a mandate that will result in the 

expenditure by State, local, and Tribal 

governments, in the aggregate, or by the 

private sector, of more than $183 

million in any 1 year. 

Executive Order 13132 establishes 

certain requirements that an agency 

must meet when it promulgates a 

proposed rule (and subsequent final 

rule) (in this case a notice) that imposes 

substantial direct requirement costs on 

State and local governments, preempts 

State law, or otherwise has federalism 

implications. Since this notice does not 

impose substantial direct costs on State 

or local governments, the requirements 

of Executive Order 13132 are not 

applicable. 

In accordance with the provisions of 

Executive Order 12866, this notice was 

reviewed by the Office of Management 

and Budget. 

The Administrator of the Centers for 

Medicare & Medicaid Services (CMS), 

Chiquita Brooks-LaSure, having 

reviewed and approved this document, 

authorizes Chyana Woodyard, who is 

the Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Chyana Woodyard, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2024–28127 Filed 11–29–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10371] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

January 31, 2025. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: ll, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10371 State-based Exchange, 

SBE, SBE Budget Template, SBE 

Enrollment Metrics, Open Enrollment 

Under the PRA (44 U.S.C. 3501– 

3520), Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires Federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collections 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: State-based 

Exchange, SBE, SBE Budget Template, 

SBE Enrollment Metrics, Open 

Enrollment; Use: The Patient Protection 


ddrumheller on DSK120RN23PROD with NOTICES1